Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

Stage III metastatic melanomas require adequate adjuvant immunotherapy to prevent relapses. Prognostic factors are awaited to optimize the clinical management of these patients. The magnitude of metastatic lymph node invasion and the BRAFV600 activating mutation have clinical significance. Based on...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Invest Dermatol
Main Authors: Jacquelot, Nicolas, Roberti, María Paula, Enot, David P., Rusakiewicz, Sylvie, Semeraro, Michaela, Jegou, Sarah, Flores, Camila, Chen, Lieping, Kwon, Byoung S., Borg, Christophe, Weide, Benjamin, Aubin, Frangois, Dalle, Stephane, Kohrt, Holbrook, Ayyoub, Maha, Kroemer, Guido, Marabelle, Aurelien, Cavalcanti, Andrea, Eggermont, Alexander, Zitvogel, Laurence
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156792/
https://ncbi.nlm.nih.gov/pubmed/26829031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2015.12.042
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker